FrancophonIA/ELRC3.0 huggingface dataset:
English: Pack size: 4 vials of powder and 4 vials of solvent.
Danish: Pakningsstørrelse: 4 hætteglas med pulver og 4 hætteglas med solvens.
English: - Somatropin Biopartners 20 mg: 20 mg (60 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a green flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in glass vial with a rubber stopper (butyl).
Danish: - Somatropin Biopartners 20 mg: 20 mg (60 IE) somatropin som pulver i et hætteglas lukket med en prop (butylgummi) og et grønt flip-off låg (aluminium og plastik) og 1,5 ml solvens (mellemkædede triglycerider) i et hætteglas med en prop (butylgummi).
English: After reconstitution, 0.2 mL of suspension contains 2 mg somatropin (10 mg/mL).
Danish: Efter rekonstitution indeholder 0,2 ml suspension 2 mg somatropin (10 mg/ml).
English: Musculoskeletal and connective tissue disorders
Danish: Hud og subkutane væv
English: - Somatropin Biopartners 7 mg: 7 mg (21 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a light-blue flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in glass vial with a rubber stopper (butyl).
Danish: - Somatropin Biopartners 7 mg: 7 mg (21 IE) somatropin som pulver i et hætteglas lukket med en prop (butylgummi) og et lyseblåt flip-off låg (aluminium og plastik) og 1,5 ml solvens (mellemkædede triglycerider) i et hætteglas med en prop (butylgummi).
English: Powder and solvent for prolonged-release suspension for injection 4 vials of 4 mg powder
Danish: Pulver og solvens til depotinjektionsvæske, suspension 4 hætteglas med 4 mg pulver 4 hætteglas med 1,5 ml solvens
English: - Somatropin Biopartners 2 mg: 2 mg (6 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a yellow flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in a glass vial with a rubber stopper (butyl).
Danish: - Somatropin Biopartners 2 mg: 2 mg (6 IE) somatropin som pulver i et hætteglas lukket med en prop (butylgummi) og et gult flip-off låg (aluminium og plastik) og 1,5 ml solvens (mellemkædede triglycerider) i et hætteglas med en prop (butylgummi).
English: - Somatropin Biopartners 4 mg: 4 mg (12 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a pink flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in glass vial with a rubber stopper (butyl).
Danish: - Somatropin Biopartners 4 mg: 4 mg (12 IE) somatropin som pulver i et hætteglas lukket med en prop (butylgummi) og et lyserødt flip-off låg (aluminium og plastik) og 1,5 ml solvens (mellemkædede triglycerider) i et hætteglas med en prop (butylgummi).
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Danish: NAVN OG ADRESSE PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN BioPartners GmbH
English: - Somatropin Biopartners 10 mg: 10 mg (30 IU) somatropin as powder in a glass vial closed with a rubber stopper (butyl) and a light-green flip-off cap (aluminium and plastic) and 1.5 mL solvent (medium chain triglycerides) in glass vial with a rubber stopper (butyl).
Danish: - Somatropin Biopartners 10 mg: 10 mg (30 IE) somatropin som pulver i et hætteglas lukket med en prop (butylgummi) og et lysegrønt flip-off låg (aluminium og plastik) og 1,5 ml solvens (mellemkædede triglycerider) i et hætteglas med en prop (butylgummi).
English: Solvent: Vial (Type I glass) closed with a rubber stopper (butyl) and a flip-off cap (aluminium and plastic).
Danish: Solvens: Hætteglas (Type I-glas) lukket med en prop (butylgummi) og et flip-off låg (aluminium og plastik).
English: MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE
Danish: A. FREMSTILLER(E) AF DET (DE) BIOLOGISK AKTIVE
English: Somatropin Biopartners 20 mg powder for prolonged-release suspension for injection somatropin
Danish: Somatropin Biopartners 20 mg pulver til depotinjektionsvæske, suspension somatropin
English: Each vial of powder delivers 20 mg somatropin; each vial of solvent contains 1.5 mL liquid.
Danish: Hvert hætteglas med pulver giver 20 mg somatropin; hvert hætteglas med solvens indeholder 1,5 mL væske.
English: Somatropin Biopartners 7 mg powder for prolonged-release suspension for injection somatropin
Danish: Somatropin Biopartners 7 mg pulver til depotinjektionsvæske, suspension somatropin
English: What Somatropin Biopartners is and what it is used for What you need to know before you use Somatropin Biopartners
Danish: Det skal du vide, før du begynder at bruge Somatropin Biopartners Sådan skal du bruge Somatropin Biopartners Bivirkninger
English: INFORMATION IN BRAILLE Somatropin Biopartners 20 mg
Danish: TEKST PÅ YDRE KARTON SOMATROPIN BIOPARTNERS 20 MG
English: Somatropin Biopartners 4 mg powder for prolonged-release suspension for injection somatropin
Danish: Somatropin Biopartners 4 mg pulver til depotinjektionsvæske, suspension somatropin
English: Each vial of powder delivers 7 mg somatropin; each vial of solvent contains 1.5 mL liquid.
Danish: Hvert hætteglas med pulver giver 7 mg somatropin; hvert hætteglas med solvens indeholder 1,5 ml væske.
English: Somatropin Biopartners 2 mg powder for prolonged-release suspension for injection somatropin
Danish: Somatropin Biopartners 2 mg pulver til depotinjektionsvæske, suspension somatropin
English: Pack size of 4 vials of powder and 4 vials of solvent.
Danish: Pakningsstørrelse på 4 hætteglas med pulver og 4 hætteglas med solvens.
English: Somatropin Biopartners 7 mg powder and solvent for prolonged-release suspension for injection Somatropin
Danish: Somatropin Biopartners 7 mg pulver og solvens til depotinjektionsvæske, suspension Somatropin
English: MARKETING AUTHORISATION NUMBER(S) EU/1/13/849/002 4 vials of powder and 4 vials of solvent
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/13/849/002 4 hætteglas med pulver og 4 hætteglas med solvens 13.
English: INFORMATION IN BRAILLE Somatropin Biopartners 4 mg
Danish: YDRE KARTON SOMATROPIN BIOPARTNERS 4 MG
English: Somatropin Biopartners 20 mg powder and solvent for prolonged-release suspension for injection somatropin
Danish: Somatropin Biopartners 20 mg pulver og solvens til depotinjektionsvæske, suspension somatropin
English: Somatropin Biopartners 2 mg powder and solvent for prolonged-release suspension for injection somatropin
Danish: Somatropin Biopartners 2 mg pulver og solvens til depotinjektionsvæske, suspension somatropin
English: INFORMATION IN BRAILLE Somatropin Biopartners 7 mg
Danish: YDRE KARTON SOMATROPIN BIOPARTNERS 7 MG
English: Scoliosis
Danish: Dosering
English: Each vial of powder delivers 2 mg somatropin; each vial of solvent contains 1.5 mL liquid.
Danish: Hvert hætteglas med pulver giver 2 mg somatropin; hvert hætteglas med solvens indeholder 1,5 ml væske.
English: Somatropin Biopartners 10 mg powder and solvent for prolonged-release suspension for injection somatropin
Danish: Somatropin Biopartners 10 mg pulver og solvens til depotinjektionsvæske, suspension somatropin
English: Somatropin Biopartners 20 mg powder and solvent for prolonged-release suspension for injection
Danish: Somatropin Biopartners 20 mg pulver og solvens til depotinjektionsvæske, suspension
English: Each vial of powder delivers 10 mg somatropin; each vial of solvent contains 1.5 mL liquid.
Danish: Hvert hætteglas med pulver giver 10 mg somatropin; hvert hætteglas med solvens indeholder 1,5 ml væske.
English: For children heavier than 20 kg, Somatropin Biopartners 20 mg powder and solvent for prolonged-release suspension for injection is available.
Danish: Somatropin Biopartners 20 mg pulver og solvens til depotinjektionsvæske, suspension er tilgængelig for børn, der vejer over 20 kg.
English: Somatropin Biopartners 4 mg powder and solvent prolonged-release for suspension for injection somatropin
Danish: Somatropin Biopartners 4 mg pulver og solvens til depotinjektionsvæske, suspension somatropin
English: MARKETING AUTHORISATION NUMBER(S) EU/1/13/849/003 4 vials of powder and 4 vials of solvent
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/13/849/003 4 hætteglas med pulver og 4 hætteglas med solvens 13.
English: 1.5 mL medium chain triglycerides
Danish: INDHOLD ANGIVET SOM VÆGT, VOLUMEN ELLER ANTAL DOSER 1,5 ml mellemkædede triglycerider
English: Somatropin Biopartners 10 mg powder and solvent for prolonged-release suspension for injection
Danish: Somatropin Biopartners 10 mg pulver og solvens til depotinjektionsvæske, suspension
English: Each vial of powder delivers 4 mg somatropin; each vial of solvent contains 1.5 mL liquid.
Danish: Hver hætteglas med pulver giver 4 mg somatropin; hvert hætteglas med solvens indeholder 1,5 ml væske.
English: Egg phospholipids
Danish: (Saccharomyces cerevisiae).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/13/849/001 4 vials of powder and 4 vials of solvent
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/13/849/001 4 hætteglas med pulver og 4 hætteglas med solvens 13.
English: Powder: Vial (type I glass) closed with a rubber stopper (butyl) and a yellow flip-off cap (aluminium and plastic).
Danish: Pulver: Hætteglas (type I-glas) lukket med en prop (butylgummi) og et gult flip-off låg (aluminium og plastik).
English: INFORMATION IN BRAILLE Somatropin Biopartners 10 mg
Danish: TEKST PÅ YDRE KARTON SOMATROPIN BIOPARTNERS 10 MG
English: Powder: Vial (type I glass) closed with a rubber stopper (butyl) and a pink flip-off cap (aluminium and plastic).
Danish: Pulver: Hætteglas (Type I-glas) lukket med en prop (butylgummi) og et lyserødt flip-off låg (aluminium og plastik).
English: NAME OF THE MEDICINAL PRODUCT Somatropin Biopartners 7 mg powder and solvent for prolonged-release suspension for injection
Danish: Somatropin Biopartners 7 mg pulver og solvens til depotinjektionsvæske, suspension
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One vial delivers 2 mg of somatropin* (corresponding to 6 IU).
Danish: Et hætteglas giver 2 mg somatropin* (svarende til 6 IE).
English: Powder: Vial (type I glass) closed with a rubber stopper (butyl) and a green flip-off cap (aluminium and plastic).
Danish: Pulver: Hætteglas (type I-glas) lukket med en prop (butylgummi) og et grønt flip-off låg (aluminium og plastik).
English: Powder: Vial (type I glass) closed with a rubber stopper (butyl) and a light-green flip-off cap (aluminium and plastic).
Danish: Pulver: Hætteglas (type I-glas) lukket med en prop (butylgummi) og et lysegrønt flip-off låg (aluminium og plastik).
English: For children up to 20 kg Somatropin Biopartners 10 mg powder and solvent for prolonged-release suspension for injection is available.
Danish: Somatropin Biopartners 10 mg pulver og solvens til depotinjektionsvæske, suspension er tilgængelig for børn, der vejer op til 20 kg.
English: NAME OF THE MEDICINAL PRODUCT Somatropin Biopartners 4 mg powder and solvent for prolonged-release suspension for injection
Danish: Somatropin Biopartners 4 mg pulver og solvens til depotinjektionsvæske, suspension
English: NAME OF THE MEDICINAL PRODUCT Somatropin Biopartners 2 mg powder and solvent for prolonged-release suspension for injection
Danish: Somatropin Biopartners 2 mg pulver og solvens til depotinjektionsvæske, suspension
English: Powder: Vial (type I glass) closed with a rubber stopper (butyl) and a light-blue flip-off cap (aluminium and plastic).
Danish: Pulver: Hætteglas (Type I-glas) lukket med en prop (butylgummi) og et lyseblåt flip-off låg (aluminium og plastik).
English: Sodium hyaluronate
Danish: Til voksne somatropin
English: It is available as 20-mg tablets.
Danish: Det fås som 20 mg-tabletter.
English: Further information on Doptelet can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/doptelet.
Danish: Yderligere information om Doptelet findes på agenturets websted under: ema.europa.eu/medicines/human/EPAR/doptelet.
English: Treatment with Doptelet should start at least 10 days before the procedure.
Danish: Behandling med Doptelet bør påbegyndes mindst 10 dage før indgrebet.
English: Other information about Doptelet
Danish: Andre oplysninger om Doptelet
English: The most common side effect with Doptelet (which may affect up to 1 in 10 people) is tiredness.
Danish: Den mest almindelige bivirkning ved Doptelet (som kan forekomme hos op til 1 ud af 10 personer) er træthed.
English: As for all medicines, data on the use of Doptelet are continuously monitored.
Danish: Som for alle lægemidler er data vedrørende brug af Doptelet løbende overvåget.
English: What is Doptelet and what is it used for?
Danish: Hvad er Doptelet, og hvad anvendes det til?
English: For more information about using Doptelet, see the package leaflet or contact your doctor or pharmacist.
Danish: For mere information om brug af Doptelet, se indlægssedlen, eller kontakt lægen eller apotekspersonalet.
English: The European Medicines Agency decided that Doptelet's benefits are greater than its risks and it can be authorised for use in the EU.
Danish: Det Europæiske Lægemiddelagentur konkluderede, at fordelene ved Doptelet opvejer risiciene, og at det kan godkendes til anvendelse i EU.
English: A blood test on the day of the procedure is necessary to ensure that the platelet count is adequate and not unexpectedly high.
Danish: Det er nødvendigt med en blodprøve på dagen for indgrebet for at sikre, at blodpladetallet er tilstrækkeligt og ikke uventet højt.
English: What measures are being taken to ensure the safe and effective use of Doptelet?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Doptelet?
English: The dose is 2 or 3 tablets (depending on the platelet count at the start of treatment), daily for 5 days.
Danish: Dosis er 2 eller 3 tabletter (afhængigt af blodpladetallet ved behandlingens begyndelse) dagligt i 5 dage.
English: An overview of Doptelet and why it is authorised in the EU
Danish: En oversigt over Doptelet, og hvorfor det er godkendt i EU
English: Side effects reported with Doptelet are carefully evaluated and any necessary action taken to protect patients.
Danish: Bivirkninger rapporteret for Doptelet vurderes omhyggeligt, og der tages de nødvendige forholdsregler for at beskytte patienterne.
English: The medicine is for use in patients having an invasive procedure (a medical procedure that involves cutting into or puncturing the skin or inserting instruments into the body).
Danish: Lægemidlet anvendes hos patienter, der skal have foretaget et invasivt indgreb (et medicinsk indgreb, der indebærer, at man ved snit eller stik trænger gennem huden, eller at man indsætter instrumenter i kroppen).
English: Doptelet can only be obtained with a prescription.
Danish: Doptelet udleveres kun efter recept.
English: Why is Doptelet authorised in the EU?
Danish: Hvorfor blev Doptelet godkendt i EU?
English: Patients with thrombocytopenia have reduced number of platelets (components in the blood that help it to clot), which can cause excessive bleeding.
Danish: Patienter med trombocytopeni har et nedsat antal blodplader (bestanddele i blodet, der hjælper det til at størkne), hvilket kan forårsage kraftig blødning.
English: Doptelet contains the active substance avatrombopag.
Danish: Doptelet indeholder det aktive stof avatrombopag.
English: Any unwanted effects during treatment with Doptelet were thought to result from patients' medical condition and the nature of the invasive procedure for which it was used.
Danish: De uønskede hændelser under behandlingen med Doptelet menes at skyldes patientens sygdom og karakteren af det invasive indgreb, som det blev anvendt til.
English: Doptelet is a medicine used to prevent excessive bleeding in adults with thrombocytopenia due to long-standing liver disease.
Danish: Doptelet er et lægemiddel, der anvendes til at forebygge kraftig blødning hos voksne med trombocytopeni som følge af langvarig leversygdom.
English: What are the risks associated with Doptelet?
Danish: Hvilke risici er der forbundet med Doptelet?
English: In these studies, 88% of patients who received Doptelet 40 mg daily did not require a transfusion or rescue procedure compared with 36% of patients who were given placebo (a dummy treatment).
Danish: I disse studier havde 88 % af de patienter, der fik 40 mg-Doptelet dagligt, ikke brug for en transfusion eller en redningsprocedure, sammenlignet med 36 % af de patienter, der fik placebo (en uvirksom behandling).
English: Among patients with more severe thrombocytopenia, 67% of those given Doptelet 60 mg daily did not require a transfusion or rescue procedure compared with 29% of those who received placebo.
Danish: Blandt patienter med svær trombocytopeni havde 67 % af de patienter, der fik 60 mgDoptelet dagligt, ikke brug for en transfusion eller en redningsprocedure, sammenlignet med 29 % af dem, der fik placebo.
English: Studies have found that Doptelet reduced the need for platelet transfusions or other rescue treatments to prevent excessive bleeding before an invasive procedure and for up to 7 days afterward.
Danish: Studier har vist, at Doptelet mindskede behovet for blodpladetransfusioner eller andre redningsbehandlinger for at forhindre kraftig blødning før et invasivt indgreb og i op til 7 dage efter.
English: The platelet count increased in patients treated with Doptelet.
Danish: Blodpladetallet steg hos patienter, der blev behandlet med Doptelet.
English: For the full list of side effects and restrictions with Doptelet, see the package leaflet.
Danish: Den fuldstændige liste over bivirkninger og begrænsninger ved Doptelet fremgår af indlægssedlen.
English: Two main studies in 435 patients with low levels of platelets due to long-standing liver disease found Doptelet effective at increasing platelet levels before an invasive procedure.
Danish: To hovedstudier, der omfattede 435 patienter med lavt antal blodplader på grund af mangeårig leversygdom, viste, at Doptelet var effektivt til at øge antallet af blodplader før et invasivt indgreb.
English: The active substance in Doptelet, avatrombopag, attaches to the same receptors as thrombopoietin, helping to increase the platelet count.
Danish: Det aktive stof i Doptelet, avatrombopag, binder sig til de samme receptorer som trombopoietin og bidrager dermed til at øge blodpladetallet.
English: How is Doptelet used?
Danish: Hvordan anvendes Doptelet?
English: What benefits of Doptelet have been shown in studies?
Danish: Hvilke fordele viser studierne, at der er ved Doptelet?
English: In the body, a hormone called thrombopoietin stimulates the production of platelets by attaching to receptors (targets) in the bone marrow.
Danish: Et hormon i kroppen, der hedder trombopoietin, stimulerer produktionen af blodplader ved at binde sig til bestemte receptorer i knoglemarven.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Doptelet have been included in the summary of product characteristics and the package leaflet.
Danish: Der er anført anbefalinger og forholdsregler i produktresuméet og indlægssedlen, som patienter og sundhedspersonale skal følge for at sikre risikofri og effektiv anvendelse af Doptelet.
English: How does Doptelet work?
Danish: Hvordan virker Doptelet?
English: The main measure of effectiveness was the number of patients who did not require a transfusion of platelets or other treatment ('rescue procedure') to prevent excessive bleeding after starting Doptelet treatment and for up to 7 days after their invasive procedure.
Danish: blodplader eller anden behandling ("redningsprocedure") for at forhindre kraftig blødning efter påbegyndelse af Doptelet-behandling og i op til 7 dage efter det invasive indgreb.
English: 10 bottles
Danish: 10 flasker
English: Strength Pharmaceutical Form Route of Administration
Danish: Særnavn Styrke Lægemiddelform
English: It is ineffective against Enterobacteriaceae.
Danish: Det er ikke effektivt mod Enterobacteriaceae.
English: Member State EU/EEA
Danish: Medlemsst at EU/EØS
English: It may be administered by oral or parenteral routes.
Danish: Det kan administreres oralt eller parenteralt.
English: Applicant/Marketing authorisation holder
Danish: Ansøger/indehaver af markedsføringstilladelse
English: Tylosin is not used in human medicine.
Danish: Tylosin anvendes ikke i humanmedicinen.
English: Treatment durations beyond three weeks
Danish: Behandling i mere end 3 uger
English: The cause for the high resistance rate can be found in the mechanisms governing the development of non-horizontal transferable resistance.
Danish: Årsagen til den høje resistensandel ligger i de mekanismer, der styrer udviklingen af ikke-horisontal overførbar resistens.
English: A recent report from Spain (Alvarez et al. (2013))
Danish: En nyere rapport fra Spanien (Alvarez et al. (2013))
English: Resistance is caused by point mutations of 23S rDNA.
Danish: Resistens skyldes punktmutationer i 23S rDNA.
English: 949 01 Nitra Slovakia
Danish: 949 01 Nitra Slovakiet
English: Product name
Danish: Produktnavn
English: 92521 Neuilly sur Seine cedex France
Danish: 92521 Neuilly sur Seine cedex Frankrig
English: Oral tylosin has had widespread use in pig farming in many EU Member States for decades to treat and prevent disease and before entry into force of Regulation (EC) No 1831/2003, as a growth promoter.
Danish: Oralt tylosin har i mange EU-medlemsstater i flere årtier haft udbredt anvendelse i svineavl til sygdomsbehandling og -forebyggelse, og før ikrafttrædelsen af forordning (EF) 1831/2003 desuden som vækstfremmer.
English: Kalinovica, 10436 Rakov Potok Croatia
Danish: Kalinovica, 10436 Rakov Potok Kroatien
English: Oral tylosin is regarded as an effective medicine against several diseases in pigs.
Danish: Oralt tylosin anses for et effektivt lægemiddel mod flere sygdomme hos svin.
English: It is active mostly against Gram-positive bacteria and mycoplasmas.
Danish: Det er hovedsagelig aktivt mod grampositive bakterier og mycoplasma.
English: th international conference on colonic spirochaetal infections in animals and humans in the United Kingdom in September 2013, it was mentioned in a key note that: “tylosin has been rendered totally ineffective through widespread use for in-feed medication over the years” (Thomson (2013))
Danish: På den sjette internationale konference om infektioner med spirokæter i kolon hos dyr og mennesker i Det Forenede Kongerige i september 2013 var en af hovedkommentarerne på linje med disse iagttagelser: “Tylosin er blevet fuldstændig virkningsløst gennem udbredt årelang anvendelse i medicineret foder” (Thomson (2013))
English: Crida Pharm SRL str. Intrarea Vagonetului nr.2, bl.101, ap.47, parter, sector 6 Bucharest
Danish: Rumænien Crida Pharm SRL str. Intrarea Vagonetului nr.2, bl.101, ap.47, parter, sector 6 Bucharest
English: 42010 Rio Saliceto (RE) Italy
Danish: 42010 Rio Saliceto (RE) Italien
English: 16 Aleia Vazrajdane str., ap.42 Bulgaria
Danish: 16 Aleia Vazrajdane str., ap.42 Bulgarien
English: The potential risk for resistance development is evident through the current resistance situation of B. hyodysenteriae.
Danish: Den potentielle risiko for udvikling af resistens fremgår klart af den nuværende resistenssituation for B. hyodysenteriae.
English: In this situation it is not to be expected that scientifically well founded justifications for treatment durations can be obtained from the different marketing authorisation holders for different indications for pigs.
Danish: I denne situation kan der ikke forventes videnskabeligt velfunderet begrundelser for behandlingsvarigheden fra forskellige markedsføringstilladelsesindehavere for forskellige indikationer til svin.
English: 12030 Cavallermaggiore (CN) Italy
Danish: 12030 Cavallermaggiore (CN) Italien
English: confirms this situation by reporting a 100% in vitro resistance among 78 isolates from pigs with diarrhoea.
Danish: bekræfter denne situation med 100 % resistens in vitro hos 78 isolater fra svin med diarré.
English: Via Don Eugenio Servadei 16 47122 Forlì, Forlì-Cesena Italy
Danish: Via Don Eugenio Servadei 16 47122 Forlì, Forlì-Cesena Italien
English: Sintofarm Via P. Togliatti, 5 Guastalla (RE) Italy
Danish: Sintofarm Via P. Togliatti, 5 Guastalla (RE) Italien